Cabot Corporation (CBT) Stock Forecast
CBT analyst forecast
as of October 18, 2026- Analyst consensus
- Buy 3.50 / 5 from 6 analysts
- Price target
- $90.33 average of analyst targets
- Upside to target
- +21.6% from the latest close
- Next earnings
- November 2, 2026 EPS estimate $1.55
- 52-week range
- $58.71 – $93.40
CBT analyst ratings
6 analystsNumber of analysts at each rating.
CBT price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
CBT earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Next quarter (Dec '26) | $1.59 | $1.59 | $1.59 | $1.53 | +3.9% | 1 |
| Current fiscal year (FY2026) | $6.37 | $6.34 | $6.42 | $7.25 | −12.2% | 6 |
| Next fiscal year (FY2027) | $6.99 | $6.70 | $7.31 | $6.37 | +9.7% | 6 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
CBT revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Next quarter (Dec '26) | $877.0M | $877.0M | $877.0M | +3.3% | 1 |
| Current fiscal year (FY2026) | $3.69B | $3.64B | $3.80B | −0.8% | 6 |
| Next fiscal year (FY2027) | $3.80B | $3.69B | $3.90B | +3.2% | 6 |
CBT EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
CBT revenue: reported and forecast
CBT EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Next quarter (Dec '26) | $1.57 | $1.51 | $1.51 | $1.51 | $1.59 | +1.4% | 0 up · 1 down |
| Current fiscal year (FY2026) | $6.32 | $6.33 | $6.36 | $6.36 | $6.37 | +0.7% | 1 up · 0 down |
| Next fiscal year (FY2027) | $7.03 | $6.96 | $6.99 | $6.99 | $6.99 | −0.6% | 1 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
CBT earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; CBT beat in 11 of 12.
What analysts expect from CBT
6 analysts cover Cabot; their consensus rating is buy (3.50 on a 1–5 scale, where 5 is a strong buy). The average price target is $90.33, 21.6% above the latest close of $74.29. Analysts expect earnings of $6.37 per share for FY2026, −12.2% from a year earlier. For FY2027 the average estimate is $6.99 per share on revenue of $3.8 billion. Cabot beat the EPS estimate in 11 of the last 12 quarters.
Related: CBT income statement, CBT key metrics, CBT chart. See the CBT stock overview for the latest quote and news.
CBT forecast FAQ
What is Cabot's price target?
The average analyst price target for Cabot is $90.33, 21.6% above the latest close of $74.29.
Is Cabot a buy, hold or sell?
Of 6 analysts covering Cabot, 2 rate it a strong buy, 0 a buy, 3 a hold, 1 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Cabot's EPS forecast?
Analysts forecast $6.37 per share for FY2026 (range $6.34 to $6.42); for FY2027 the estimate is $6.99.
What is Cabot's revenue forecast?
The average revenue estimate for FY2026 is $3.7 billion, growth of −0.8%; for FY2027 it is $3.8 billion.
When does Cabot report earnings?
Cabot is expected to report results for the quarter ending September 30, 2026 on November 2, 2026 after the market closes; the EPS estimate is $1.55.
Does Cabot usually beat earnings estimates?
Cabot reported EPS at or above the analyst estimate in 11 of the last 12 quarters.